[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neuren Pharmaceuticals Ltd (NEU.AX)

Neuren Pharmaceuticals Ltd (NEU.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Neuren Pharmaceuticals Ltd 117 Camberwell Road Suite 1.01 Melbourne VIC 3123 AUS

https://www.neurenpharma.com P: +61 390920480

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome. The Group has two reportable operating segments, Commercial Products and Research and Development. It derives maximum revenue from Commercial Products.

Key Statistics

Overview:

Market Capitalization, $K 2,071,487
Shares Outstanding, K 126,774
% of Institutional Shareholders 26.43%

Financials:

Annual Sales, $ 64,634 K
Annual Net Income, $ 30,436 K

Growth:

1-Year Return 18.34%
3-Year Return 23.18%
5-Year Return 926.99%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm 0.23
EPS Growth vs. Prev Year -0.79%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 11/21/17

NEU.AX Ratios

Ratio
Price/Earnings ttm 70.22
Price/Earnings forward 65.36
Return-on-Equity % 8.67%
Return-on-Assets % 8.09%
Profit Margin % 47.09%
Debt/Equity N/A
Price/Sales 33.88
Price/Book 6.12
Book Value/Share 2.67
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.